Danielle Van Manen

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity.

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity.

Journal: Scientific reports

Published: November 13, 2023

Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.

Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 09, 2023

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.

Journal: Nature communications

Published: September 21, 2023

Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Journal: Nature

Published: January 20, 2021

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.

Journal: NPJ vaccines

Published: July 30, 2020

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Journal: Nature

Published: June 20, 2020

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Journal: Lancet (London, England)

Published: May 18, 2018

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys.

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys.

Journal: Journal of virology

Published: March 28, 2018

A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.

A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.

Journal: Cell reports

Published: December 05, 2017

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 11, 2015

Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs.

Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs.

Journal: PloS one

Published: April 22, 2015

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 28, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026